Uprosertib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Uprosertib, covering 2020-10-14 to 2020-10-14. Get the full timeline:
Most recent: Clinical Trial Update: Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer [Phase 1, Phase 2]